These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3951326)

  • 1. Absorption of intragastrically administered DDAVP in conscious dogs.
    Lundin S; Vilhardt H
    Life Sci; 1986 Feb; 38(8):703-9. PubMed ID: 3951326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
    Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.
    Lundin S; Melin P; Vilhardt H
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):179-83. PubMed ID: 3969814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.
    Pullan PT; Burger HG; Johnston CI
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):273-8. PubMed ID: 709897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma kinetics of DDAVP in man.
    Vilhardt H; Lundin S; Falch J
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):379-81. PubMed ID: 3739732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses.
    Mannucci PM; Vicente V; Alberca I; Sacchi E; Longo G; Harris AS; Lindquist A
    Thromb Haemost; 1987 Dec; 58(4):1037-9. PubMed ID: 3127916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus.
    Sørensen PS; Vilhardt H; Gjerris F; Warberg J
    Eur J Clin Invest; 1984 Dec; 14(6):435-9. PubMed ID: 6441719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans.
    Vilhardt H; Lundin S
    Gen Pharmacol; 1986; 17(4):481-3. PubMed ID: 3758654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of factor VIII after administration of DDAVP to conscious dogs.
    Vilhardt H; Barth T; Falch J; Nilsson IM
    Thromb Res; 1987 Sep; 47(5):585-91. PubMed ID: 3118500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP and extrarenal vasopressin V2 receptors in dogs.
    Liard JF
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1888-91. PubMed ID: 1336316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in man.
    d'Agay-Abensour L; Fjellestad-Paulsen A; Höglund P; Ngô Y; Paulsen O; Rambaud JC
    Eur J Clin Pharmacol; 1993; 44(5):473-6. PubMed ID: 8359185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of 1-deamino-8-D-arginine vasopressin with an enzyme inhibitor (aprotinin) from the small intestine in healthy volunteers.
    Fjellestad-Paulsen A; d'Agay-Abensour L; Höglund P; Rambaud JC
    Eur J Clin Pharmacol; 1996; 50(6):491-5. PubMed ID: 8858277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits.
    Lundin S; Vilhardt H
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):457-60. PubMed ID: 3751460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does DDAVP (1-desamino-8-D-arginine-vasopressin) cross the blood-CSF barrier?
    Stegner H; Artman HG; Leake RD; Fisher DA
    Neuroendocrinology; 1983 Oct; 37(4):262-5. PubMed ID: 6633816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability and perfusion studies of Desmopressin (dDAVP) and prodrugs in the rat jejunum.
    Lepist EI; Ostergaard J; Fredholt K; Lennernäs H; Friis GJ
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):363-8. PubMed ID: 10445399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.